Predicate Research Report · generated 2026-08-22 · Print / save as PDF · Save to account
Roche Diagnostics GmbH — Predicate Candidate Screening
5 FDA 510(k) clearances under this manufacturer; the 50 most recent screened below.
23 daysmedian FDA review time
266 days90th percentile
5clearances measured
| K-number | Device | Applicant | Decided | Review days | Recalls (K-match) |
|---|---|---|---|---|---|
| K252431 | Elecsys Calcitonin | Roche Diagnostics GmbH | 2026-04-24 | 266 | 0 |
| K143446 | Accu-Chek FlexLink Plus infusion set | Roche Diagnostics GmbH | 2015-08-13 | 254 | 0 |
| K981282 | ELECSYS AFP | Roche Diagnostics GmbH | 1998-05-01 | 23 | 0 |
| K981281 | ELECSYS CALCHECK FERRITIN | Roche Diagnostics GmbH | 1998-04-24 | 16 | 0 |
| K981278 | ELECSYS CALCHECK CA 125II | Roche Diagnostics GmbH | 1998-04-23 | 15 | 0 |
Methodology
Recall counts reflect FDA recall records explicitly referencing each K-number; FDA links recalls to K-numbers inconsistently, so 0 means "none found in FDA records," not "never recalled." Data: FDA openFDA, refreshed weekly. Verify decisions of consequence against the primary source. Full candidate set and CSV export: atlasbyauro.com.
Prepared with Atlas
Predicate research, review-time statistics and recall monitoring for 510(k) teams — atlasbyauro.com/fda